Zhigang Liang
Papers
1
Total Citations
16
H-Index
1
About
Zhigang Liang is a rising star in the field of biosensing and molecular diagnostics, with a focus on CRISPR-based technologies. His work centers on the innovative use of DNA nanotechnology to precisely control the activity of the CRISPR/Cas12a system, a revolutionary genome editing tool. In his highly cited 2024 paper, "DNA Robots for CRISPR/Cas12a Activity Management and Universal Platforms for Biosensing," Liang introduced a novel approach to manage Cas12a's trans-cleavage activity through simple DNA modifications—a challenge that had seen few solutions. This breakthrough enables the creation of universal biosensing platforms, offering unprecedented versatility for detecting a wide range of targets. With 16 citations in its first year, the work has already captured significant attention for its potential to transform molecular diagnostics. By bridging DNA robotics and CRISPR, Liang is paving the way for more precise, adaptable, and user-friendly diagnostic tools, marking him as a key innovator in the next generation of biosensing technologies.
Research Focus
Key Achievements
Top Papers
- 1